MedTrace Logo

Phase 1b Malaria Clinical Trial Using Argemone Mexicana in Healthy Adults in Mali

NCT01645254 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2012-10-03

No results posted yet for this study

Summary

The main objective is to study the pharmacokinetics, pharmacodynamics and tolerability of the decoction of the aerial parts of Argemone mexicana (AM), administered in healthy volunteers.

Conditions

Interventions

DRUG

Argemone mexicana

30g, the powder decoction 2 times a day for 14 days

Sponsors & Collaborators

  • University of Geneva, Switzerland

    collaborator OTHER

  • University of Bamako

    lead OTHER

Principal Investigators

  • Issaka Sagara, MD,MSPH · University of Bamako

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2012-10-31
Completion
2012-11-30

Countries

  • Mali

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01645254 on ClinicalTrials.gov